IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
Retrieved on:
Friday, January 12, 2024
WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the IDEXX inVue Dx™ Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples. With deep AI learning models trained by IDEXX board-certified pathologists, the in-clinic analyzer provides practitioners with reference-laboratory quality results in 10 minutes. Unlike traditional slide methods, the IDEXX inVue Dx analyzer examines cells in their natural state, providing multidimensional images of sample findings and enabling diagnostic insights like never before.
Key Points:
- With deep AI learning models trained by IDEXX board-certified pathologists, the in-clinic analyzer provides practitioners with reference-laboratory quality results in 10 minutes.
- Unlike traditional slide methods, the IDEXX inVue Dx analyzer examines cells in their natural state, providing multidimensional images of sample findings and enabling diagnostic insights like never before.
- The IDEXX inVue Dx platform's capabilities will grow over time, with expansion to screening lumps and bumps with fine needle aspirate samples planned next.
- "Veterinary professionals are exceedingly busy and are eager for ways to increase capacity," said Jay Mazelsky, President and Chief Executive Officer of IDEXX.